New ‘vaccine-like’ HIV drug may price simply $40: researchers

Science Information: Gilead’s HIV drug Lenacapavir may cut back prices from $40,000 to $40, aiding high-risk teams. UNAIDS and Byanyima urge licensing through the Medicines Pa

Source